Clinical and MRI measures to identify non-acute MOG-antibody disease in adults

Clinical and MRI measures to identify non-acute MOG-antibody disease in adults

Abstract MRI and clinical features of myelin oligodendrocyte glycoprotein (MOG)-antibody disease may overlap with those of other inflammatory demyelinating conditions posing diagnostic challenges, especially in non-acute phases and when serologic testing for MOG antibodies is unavailable or shows un...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Rosa Cortese, Marco Battaglini, Ferrán Prados, Alessia Bianchi, Lukas Haider, Anu Jacob, Jacqueline Palace, Silvia Messina, Friedemann Paul, Jens Wuerfel, Romain Marignier, Françoise Durand‐Dubief, Carolina de Medeiros Rimkus, Dagoberto Callegaro, Douglas Kazutoshi Sato, Massimo Filippi, Maria A. Rocca, Laura Cacciaguerra, Àlex Rovira, Jaume Sastre‐Garriga, Georgina Arrambide, Yaou Liu, Yunyun Duan, Claudio Gasperini, Carla Tortorella, Serena Ruggieri, Maria Pia Amato, Monica Ulivelli, Sergiu Groppa, Matthias Grothe, Sara Llufriú, María Sepúlveda, Carsten Lukas, Barbara Bellenberg, Ruth Schneider, Piotr Sowa, Elisabeth Gulowsen Celius, Anne‐Katrin Proebstel, Özgür Yaldizli, Jannis Müller, Bruno Stankoff, Benedetta Bodini, Luca Carmisciano, Maria Pia Sormani, Frederik Barkhof, Nicola De Stefano, Olga Ciccarelli, C Enzinger, Ludwig Kappos, J Palace, Hugo Vrenken, Tarek Yousry
Formato: Artigo
Lenguaje:inglés
Publicado: 2022
Acceso en línea:https://doi.org/10.1093/brain/awac480
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doi.org/10.1093/brain/awac480

Ejemplares similares